The investment landscape is equally impressive. In the PitchBook database, we find around 100 companies focused on targeting the hallmarks of aging, with more than 470 investors participating across 277 deals. The investment momentum is substantial, with $11.8bn total capital invested in the sector. Between April 2024 and March 2025, $1.6bn was invested, with the median deal size reaching $10.6m – a 51% year-over-year increase. Perhaps even more telling is the 49% year-over-year growth in median post-money valuation, which reached $61.4m, signaling strong investor confidence in the sector’s potential.
The core market features well-funded startups and established players pursuing diverse scientific approaches. Altos Labs, founded in 2021 and backed by Jeff Bezos among others, has raised an extraordinary $5.6bn to pursue cellular reprogramming technologies. Human Longevity, established in 2013, has secured $1.1bn for its genomics-focused approach to extending healthy lifespan. Other players include InSilico Medicine (founded in 2014, $536.3m raised), which leverages AI for drug discovery targeting aging pathways, and Unity Biotechnology (founded in 2009, $355.3m raised), which leads the field in senolytic therapies. Juvenescence (founded in 2017, $231.7m raised) and Life Biosciences (founded in 2017, $175.2m raised) round out the top tier of well-funded companies, both pursuing platform approaches to longevity.
The broader market: translating science into solutions
The scientific understanding of the biological mechanisms of aging is being translated into commercial solutions across multiple market segments. This represents the next level of our framework.
Consumer goods companies are at the forefront, manufacturing wellness and lifecycle products that represent 26% of the ecosystem. These range from anti-aging skincare, hair, and body products to nutraceuticals, supplements, food, and drinks. Companies like Nestlé Health Science offer products that target specific aspects of aging, such as Celltrient, which focuses on cellular nutrition and mitochondrial health. ChromaDex’s Tru Niagen supplement aims to boost NAD+ levels, a coenzyme that declines with age and is critical for cellular energy production. This sub-market is also seeing a rise in biohacking products and services: tools that enable consumers to measure, analyze, and modify their biology through data-driven experimentation, such as glucose monitors or sleep optimization.
Longevity therapeutics companies (8%) are focusing on reversing age-related damage through cellular rejuvenation, tissue engineering, and regenerative medicine. Diagnostic and monitoring technologies (5%) measure biological age and track the effectiveness of interventions, from biomarker panels, multiomics platforms, and wearable devices to medical devices for regenerative therapies.
Thanks to the research and development efforts of these companies, preventative solutions such as microbiome optimization or metabolic health interventions can address aging before damage occurs. Personalized interventions recognize variations in aging, providing custom formulations and protocols. Finally, an emerging longevity real estate sector is creating living environments designed to promote health and wellness.
Distribution channels: connecting solutions with people
Longevity products and services can only create impact when they reach consumers. The next level of our framework maps the distribution channels that connect scientific innovations and commercial solutions with the individuals who benefit from them.
These channels have evolved to address the unique needs of longevity interventions, which often require specialized knowledge, ongoing monitoring, and integration across multiple approaches. Specialized longevity care providers (44%) offer anti-aging and regenerative medicine services through various settings such as longevity clinics, med spas, integrative and functional medicine practices, and compounding pharmacies.
Beauty, wellness, and fitness service providers (6%) combine offerings such as fitness training with nutritional guidance to support longevity goals. Digital health and connectivity platforms (3%) have dramatically expanded access through AI-powered health monitoring and virtual aging clinics, allowing remote engagement with longevity solutions.
Consumer access points, including membership programs and direct-to-consumer testing, make consumer-oriented interventions more widely accessible, while integrated physical and virtual communities combine multiple longevity interventions with social support networks, creating environments where preventative practices, monitoring technologies, and lifestyle changes are integrated into daily living. Professional networks support specialized knowledge requirements through physician education and certification programs.